<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38675915</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>08</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Quantitation of Enterovirus A71 Empty and Full Particles by Sedimentation Velocity Analytical Ultracentrifugation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">573</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16040573</ELocationID><Abstract><AbstractText>The enterovirus A71 (EV71) inactivated vaccine is an effective intervention to control the spread of the virus and prevent EV71-associated hand, foot, and mouth disease (HFMD). It is widely administered to infants and children in China. The empty particles (EPs) and full particles (FPs) generated during production have different antigenic and immunogenic properties. However, the antigen detection methods currently used were established without considering the differences in antigenicity between EPs and FPs. There is also a lack of other effective analytical methods for detecting the different particle forms, which hinders the consistency between batches of products. In this study, we analyzed the application of sedimentation velocity analytical ultracentrifugation (SV-AUC) in characterizing the EPs and FPs of EV71. Our results showed that the proportions of the two forms could be quantified simultaneously by SV-AUC. We also determined the repeatability and accuracy of this method and found that both parameters were satisfactory. We assessed SV-AUC for bulk vaccine quality control, and our findings indicated that SV-AUC can be used effectively to analyze the percentage of EPs and FPs and monitor the consistency of the process to ensure the quality of the vaccine.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Engineering Technology Research Center of Combined Vaccines, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Laboratory for Novel Vaccines Research and Development of Emerging Infectious Diseases, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Provincial Vaccines Technology Innozation Center, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Research Core Facilities for Life Science (HUST), College of Life Science and Technology, Huazhong University of Science and Technology, Luoyu Road, Wuhan 430074, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Engineering Technology Research Center of Combined Vaccines, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Laboratory for Novel Vaccines Research and Development of Emerging Infectious Diseases, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Provincial Vaccines Technology Innozation Center, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Tingbo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Engineering Technology Research Center of Combined Vaccines, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Laboratory for Novel Vaccines Research and Development of Emerging Infectious Diseases, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Provincial Vaccines Technology Innozation Center, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wenhui</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Engineering Technology Research Center of Combined Vaccines, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Laboratory for Novel Vaccines Research and Development of Emerging Infectious Diseases, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Provincial Vaccines Technology Innozation Center, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Engineering Technology Research Center of Combined Vaccines, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Laboratory for Novel Vaccines Research and Development of Emerging Infectious Diseases, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Provincial Vaccines Technology Innozation Center, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Kaiwen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Engineering Technology Research Center of Combined Vaccines, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Laboratory for Novel Vaccines Research and Development of Emerging Infectious Diseases, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Provincial Vaccines Technology Innozation Center, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Deqin</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Engineering Technology Research Center of Combined Vaccines, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Laboratory for Novel Vaccines Research and Development of Emerging Infectious Diseases, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Provincial Vaccines Technology Innozation Center, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Dongsheng</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Engineering Technology Research Center of Combined Vaccines, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Laboratory for Novel Vaccines Research and Development of Emerging Infectious Diseases, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Provincial Vaccines Technology Innozation Center, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Hanyu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Engineering Technology Research Center of Combined Vaccines, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Laboratory for Novel Vaccines Research and Development of Emerging Infectious Diseases, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Provincial Vaccines Technology Innozation Center, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Engineering Technology Research Center of Combined Vaccines, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Laboratory for Novel Vaccines Research and Development of Emerging Infectious Diseases, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Provincial Vaccines Technology Innozation Center, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Shengli</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Engineering Technology Research Center of Combined Vaccines, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Laboratory for Novel Vaccines Research and Development of Emerging Infectious Diseases, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Provincial Vaccines Technology Innozation Center, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Engineering Technology Research Center of Combined Vaccines, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Laboratory for Novel Vaccines Research and Development of Emerging Infectious Diseases, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Provincial Vaccines Technology Innozation Center, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zejun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Engineering Technology Research Center of Combined Vaccines, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Laboratory for Novel Vaccines Research and Development of Emerging Infectious Diseases, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Provincial Vaccines Technology Innozation Center, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Shuo</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0916-053X</Identifier><AffiliationInfo><Affiliation>Wuhan Institute of Biological Products Co., Ltd., No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Engineering Technology Research Center of Combined Vaccines, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Key Laboratory for Novel Vaccines Research and Development of Emerging Infectious Diseases, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Provincial Vaccines Technology Innozation Center, No. 1 Huangjin Industrial Park Road, Wuhan 430207, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2015ZX09102021</GrantID><Agency>Ministry of Science and Technology of the People's Republic of China</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015164">Vaccines, Inactivated</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014461" MajorTopicYN="Y">Ultracentrifugation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015164" MajorTopicYN="N">Vaccines, Inactivated</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014771" MajorTopicYN="N">Virion</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011786" MajorTopicYN="N">Quality Control</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV71 inactivated vaccine</Keyword><Keyword MajorTopicYN="N">SV-AUC</Keyword><Keyword MajorTopicYN="N">empty particles</Keyword><Keyword MajorTopicYN="N">full particles</Keyword><Keyword MajorTopicYN="N">quality control</Keyword></KeywordList><CoiStatement>Authors Anna Yang, Jie Yang, Tingbo Xie, Wenhui Wang, Xin Wan, Kaiwen Wang, Deqin Pang, Dongsheng Yang, Hanyu Dai, Jie Wu, Shengli Meng, Jing Guo, Zejun Wang and Shuo Shen was employed by the company Wuhan Institute of Biological Products Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>1</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38675915</ArticleId><ArticleId IdType="pmc">PMC11053756</ArticleId><ArticleId IdType="doi">10.3390/v16040573</ArticleId><ArticleId IdType="pii">v16040573</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fang C.Y., Liu C.C. Novel strategies for the development of hand, foot, and mouth disease vaccines and antiviral therapies. Expert Opin. Drug Discov. 2022;17:27–39. doi: 10.1080/17460441.2021.1965987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17460441.2021.1965987</ArticleId><ArticleId IdType="pubmed">34382876</ArticleId></ArticleIdList></Reference><Reference><Citation>Min N., Ong Y.H.B., Han A.X., Ho S.X., Yen E.W.P., Ban K.H.K., Maurer-Stroh S., Chong C.Y., Chu J.J.H. An epidemiological surveillance of hand foot and mouth disease in paediatric patients and in community: A Singapore retrospective cohort study, 2013–2018. PLoS Negl. Trop. Dis. 2021;15:e0008885. doi: 10.1371/journal.pntd.0008885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0008885</ArticleId><ArticleId IdType="pmc">PMC7901731</ArticleId><ArticleId IdType="pubmed">33566802</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Yeo A., Phoon M.C., Tan E.L., Poh C.L., Quak S.H., Chow V.T. The largest outbreak of hand; foot and mouth disease in Singapore in 2008: The role of enterovirus 71 and coxsackievirus A strains. Int. J. Infect. Dis. 2010;14:e1076–e1081. doi: 10.1016/j.ijid.2010.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2010.07.006</ArticleId><ArticleId IdType="pubmed">20952237</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander J.P., Jr., Baden L., Pallansch M.A., Anderson L.J. Enterovirus 71 infections and neurologic disease—United States, 1977–1991. J. Infect. Dis. 1994;169:905–908. doi: 10.1093/infdis/169.4.905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/169.4.905</ArticleId><ArticleId IdType="pubmed">8133108</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan K.P., Goh K.T., Chong C.Y., Teo E.S., Lau G., Ling A.E. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg. Infect. Dis. 2003;9:78–85. doi: 10.3201/eid1301.020112.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1301.020112</ArticleId><ArticleId IdType="pmc">PMC2873753</ArticleId><ArticleId IdType="pubmed">12533285</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K.T., Chang H.L., Wang S.T., Cheng Y.T., Yang J.Y. Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998–2005. Pediatrics. 2007;120:e244–e252. doi: 10.1542/peds.2006-3331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2006-3331</ArticleId><ArticleId IdType="pubmed">17671037</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt N.J., Lennette E.H., Ho H.H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 1974;129:304–309. doi: 10.1093/infdis/129.3.304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Lewthwaite P., Perera D., Cardosa M.J., McMinn P., Ooi M.H. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010;10:778–790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng M., Pu D., Mo X., Zhu C., Gong S., Xu Y., Lin G., Wu B., He S., Jiao X., et al. Children of rural-to-urban migrant workers in China are at a higher risk of contracting severe hand, foot and mouth disease and EV71 infection: A hospital-based study. Emerg. Microbes Infect. 2013;2:e72. doi: 10.1038/emi.2013.72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2013.72</ArticleId><ArticleId IdType="pmc">PMC3826070</ArticleId><ArticleId IdType="pubmed">26038441</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J.X., Song Y.F., Wang L., Zhang X.F., Hu Y.S., Hu Y.M., Xia J.L., Li J., Zhu F.C. Two-year efficacy and immunogenicity of Sinovac Enterovirus 71 vaccine against hand, foot and mouth disease in children. Expert Rev. Vaccines. 2016;15:129–137. doi: 10.1586/14760584.2016.1096782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2016.1096782</ArticleId><ArticleId IdType="pubmed">26460695</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Liu L., Mo Z., Wang X., Xia J., Liang Z., Zhang Y., Li Y., Mao Q., Wang J., et al. An inactivated enterovirus 71 vaccine in healthy children. N. Engl. J. Med. 2014;370:829–837. doi: 10.1056/NEJMoa1303224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1303224</ArticleId><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q.Y., Wang Y., Bian L., Xu M., Liang Z. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD) Expert Rev. Vaccines. 2016;15:599–606. doi: 10.1586/14760584.2016.1138862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2016.1138862</ArticleId><ArticleId IdType="pubmed">26732723</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y., Guo X., Zhang M., Chen Y., Zhang Y., Yu X., Luo L., Chen H., Xu W., Liu H., et al. Safety and Immunogenicity of Enterovirus 71 Vaccine (Vero Cell) Administered Simultaneously with Trivalent Split-Virion Influenza Vaccine in Infants Aged 6-7 Months: A Phase 4, Randomized, Controlled Trial. Vaccines. 2023;11:862. doi: 10.3390/vaccines11040862.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11040862</ArticleId><ArticleId IdType="pmc">PMC10146551</ArticleId><ArticleId IdType="pubmed">37112774</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F., Xu W., Xia J., Liang Z., Liu Y., Zhang X., Tan X., Wang L., Mao Q., Wu J., et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N. Engl. J. Med. 2014;370:818–828. doi: 10.1056/NEJMoa1304923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1304923</ArticleId><ArticleId IdType="pubmed">24571754</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F.C., Meng F.Y., Li J.X., Li X.L., Mao Q.Y., Tao H., Zhang Y.T., Yao X., Chu K., Chen Q.H., et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013;381:2024–2032. doi: 10.1016/S0140-6736(13)61049-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61049-1</ArticleId><ArticleId IdType="pubmed">23726161</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown B.A., Pallansch M.A. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res. 1995;39:195–205. doi: 10.1016/0168-1702(95)00087-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(95)00087-9</ArticleId><ArticleId IdType="pubmed">8837884</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B. Universal PCR Primers Are Critical for Direct Sequencing-Based Enterovirus Genotyping. J. Clin. Microbiol. 2017;55:339–340. doi: 10.1128/JCM.01801-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01801-16</ArticleId><ArticleId IdType="pmc">PMC5228251</ArticleId><ArticleId IdType="pubmed">28031445</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B.M., Mulkey S.B., Campos J.M., DeBiasi R.L. Laboratory diagnosis of CNS infections in children due to emerging and re-emerging neurotropic viruses. Pediatr. Res. 2024;95:543–550. doi: 10.1038/s41390-023-02930-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-023-02930-6</ArticleId><ArticleId IdType="pubmed">38042947</ArticleId></ArticleIdList></Reference><Reference><Citation>Shingler K.L., Yoder J.L., Carnegie M.S., Ashley R.E., Makhov A.M., Conway J.F., Hafenstein S. The enterovirus 71 A-particle forms a gateway to allow genome release: A cryoEM study of picornavirus uncoating. PLoS Pathog. 2013;9:e1003240. doi: 10.1371/annotation/e92d19e0-996a-4bfa-afdd-20dce770ed75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/annotation/e92d19e0-996a-4bfa-afdd-20dce770ed75</ArticleId><ArticleId IdType="pmc">PMC3605244</ArticleId><ArticleId IdType="pubmed">23555253</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Peng W., Ren J., Hu Z., Xu J., Lou Z., Li X., Yin W., Shen X., Porta C., et al. A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat. Struct. Mol. Biol. 2012;19:424–429. doi: 10.1038/nsmb.2255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2255</ArticleId><ArticleId IdType="pmc">PMC3378640</ArticleId><ArticleId IdType="pubmed">22388738</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., Zheng Q., Li S., He M., Wu Y., Li Y., Zhu R., Yu H., Hong Q., Jiang J., et al. Atomic structures of Coxsackievirus A6 and its complex with a neutralizing antibody. Nat. Commun. 2017;8:505. doi: 10.1038/s41467-017-00477-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00477-9</ArticleId><ArticleId IdType="pmc">PMC5593947</ArticleId><ArticleId IdType="pubmed">28894095</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao J., Liu H., Qu M., Hou A., Zhou Y., Sun B., Cai L., Gao F., Su W., Jiang C. Determination of the cleavage site of enterovirus 71 VP0 and the effect of this cleavage on viral infectivity and assembly. Microb. Pathog. 2019;134:103568. doi: 10.1016/j.micpath.2019.103568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2019.103568</ArticleId><ArticleId IdType="pubmed">31195113</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C.Y., Yu S.L., Chen Y.T., Chen Y.H., Hsiao P.W., Chow Y.H., Chen J.R. The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus. PLoS ONE. 2019;14:e0210553. doi: 10.1371/journal.pone.0210553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0210553</ArticleId><ArticleId IdType="pmc">PMC6334917</ArticleId><ArticleId IdType="pubmed">30650163</ArticleId></ArticleIdList></Reference><Reference><Citation>Tedcastle A., Mao Q., Hockley J., Pegg E., EV71 Study Group. Gao F., Liang Z., Matejtschuk P., Duru C., Minor P., et al. Report on the WHO Collaborative Study to Establish the 1st International Standard for Enterovirus A71 Inactivated Vaccine. WHO; Geneva, Switzerland: 2019.</Citation></Reference><Reference><Citation>Sawyer L.A., McInnis J., Albrecht P. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains. Biologicals. 1993;21:169–177. doi: 10.1006/biol.1993.1070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/biol.1993.1070</ArticleId><ArticleId IdType="pubmed">8297601</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouiavskaia D., Puligedda R.D., Dessain S.K., Chumakov K. Universal ELISA for quantification of D-antigen in inactivated poliovirus vaccines. J. Virol. Methods. 2020;276:113785. doi: 10.1016/j.jviromet.2019.113785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2019.113785</ArticleId><ArticleId IdType="pubmed">31765719</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommer J.M., Smith P.H., Parthasarathy S., Isaacs J., Vijay S., Kieran J., Powell S.K., McClelland A., Wright J.F. Quantification of adeno-associated virus particles and empty capsids by optical density measurement. Mol. Ther. 2003;7:122–128. doi: 10.1016/S1525-0016(02)00019-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1525-0016(02)00019-9</ArticleId><ArticleId IdType="pubmed">12573625</ArticleId></ArticleIdList></Reference><Reference><Citation>Lock M., Alvira M.R., Wilson J.M. Analysis of particle content of recombinant adeno-associated virus serotype 8 vectors by ion-exchange chromatography. Hum. Gene Ther. Methods. 2012;23:56–64. doi: 10.1089/hgtb.2011.217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hgtb.2011.217</ArticleId><ArticleId IdType="pmc">PMC4015067</ArticleId><ArticleId IdType="pubmed">22428980</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnham B., Nass S., Kong E., Mattingly M., Woodcock D., Song A., Wadsworth S., Cheng S.H., Scaria A., O’Riordan C.R. Analytical Ultracentrifugation as an Approach to Characterize Recombinant Adeno-Associated Viral Vectors. Hum. Gene Ther. Methods. 2015;26:228–242. doi: 10.1089/hgtb.2015.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hgtb.2015.048</ArticleId><ArticleId IdType="pubmed">26414997</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierson E.E., Keifer D.Z., Asokan A., Jarrold M.F. Resolving Adeno-Associated Viral Particle Diversity with Charge Detection Mass Spectrometry. Anal. Chem. 2016;88:6718–6725. doi: 10.1021/acs.analchem.6b00883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.6b00883</ArticleId><ArticleId IdType="pmc">PMC6537880</ArticleId><ArticleId IdType="pubmed">27310298</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian S., Maurer A.C., Bator C.M., Makhov A.M., Conway J.F., Turner K.B., Marden J.H., Vandenberghe L.H., Hafenstein S.L. Filling Adeno-Associated Virus Capsids: Estimating Success by Cryo-Electron Microscopy. Hum. Gene Ther. 2019;30:1449–1460. doi: 10.1089/hum.2019.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hum.2019.041</ArticleId><ArticleId IdType="pmc">PMC6921155</ArticleId><ArticleId IdType="pubmed">31530236</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntosh N.L., Berguig G.Y., Karim O.A., Cortesio C.L., De Angelis R., Khan A.A., Gold D., Maga J.A., Bhat V.S. Comprehensive characterization and quantification of adeno associated vectors by size exclusion chromatography and multi angle light scattering. Sci. Rep. 2021;11:3012. doi: 10.1038/s41598-021-82599-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-82599-1</ArticleId><ArticleId IdType="pmc">PMC7862616</ArticleId><ArticleId IdType="pubmed">33542328</ArticleId></ArticleIdList></Reference><Reference><Citation>Khasa H., Kilby G., Chen X., Wang C. Analytical band centrifugation for the separation and quantification of empty and full AAV particles. Mol. Ther. Methods Clin. Dev. 2021;21:585–591. doi: 10.1016/j.omtm.2021.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtm.2021.04.008</ArticleId><ArticleId IdType="pmc">PMC8142049</ArticleId><ArticleId IdType="pubmed">34095342</ArticleId></ArticleIdList></Reference><Reference><Citation>Werle A.K., Powers T.W., Zobel J.F., Wappelhorst C.N., Jarrold M.F., Lyktey N.A., Sloan C.D.K., Wolf A.J., Adams-Hall S., Baldus P., et al. Comparison of analytical techniques to quantitate the capsid content of adeno-associated viral vectors. Mol. Ther. Methods Clin. Dev. 2021;23:254–262. doi: 10.1016/j.omtm.2021.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtm.2021.08.009</ArticleId><ArticleId IdType="pmc">PMC8505359</ArticleId><ArticleId IdType="pubmed">34703846</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarawsky A.E., Zai-Rose V., Cunningham H.M., Burgner J.W., 2nd, DeLion M.T., Paul L.N. AAV analysis by sedimentation velocity analytical ultracentrifugation: Beyond empty and full capsids. Eur. Biophys. J. 2023;52:353–366. doi: 10.1007/s00249-023-01646-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00249-023-01646-z</ArticleId><ArticleId IdType="pubmed">37037926</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuck P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys. J. 2000;78:1606–1619. doi: 10.1016/S0006-3495(00)76713-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-3495(00)76713-0</ArticleId><ArticleId IdType="pmc">PMC1300758</ArticleId><ArticleId IdType="pubmed">10692345</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkowitz S.A., Philo J.S. Monitoring the homogeneity of adenovirus preparations (a gene therapy delivery system) using analytical ultracentrifugation. Anal. Biochem. 2007;362:16–37. doi: 10.1016/j.ab.2006.11.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ab.2006.11.031</ArticleId><ArticleId IdType="pubmed">17223062</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Agarwala S., Ravindran S., Vellekamp G. Determination of particle heterogeneity and stability of recombinant adenovirus by analytical ultracentrifugation in CsCl gradients. J. Pharm. Sci. 2008;97:746–763. doi: 10.1002/jps.21008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jps.21008</ArticleId><ArticleId IdType="pubmed">17593554</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuck P. Sedimentation analysis of noninteracting and self-associating solutes using numerical solutions to the Lamm equation. Biophys. J. 1998;75:1503–1512. doi: 10.1016/S0006-3495(98)74069-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-3495(98)74069-X</ArticleId><ArticleId IdType="pmc">PMC1299825</ArticleId><ArticleId IdType="pubmed">9726952</ArticleId></ArticleIdList></Reference><Reference><Citation>Dam J., Schuck P. Calculating sedimentation coefficient distributions by direct modeling of sedimentation velocity concentration profiles. Methods Enzymol. 2004;384:185–212. doi: 10.1016/S0076-6879(04)84012-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0076-6879(04)84012-6</ArticleId><ArticleId IdType="pubmed">15081688</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao D., Sun B., Sun S., Fu B., Liu C., Liu D., Chu Y., Ma Y., Bai L., Wu Y., et al. Characterization of human enterovirus71 virus-like particles used for vaccine antigens. PLoS ONE. 2017;12:e0181182. doi: 10.1371/journal.pone.0181182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0181182</ArticleId><ArticleId IdType="pmc">PMC5521781</ArticleId><ArticleId IdType="pubmed">28732070</ArticleId></ArticleIdList></Reference><Reference><Citation>Lien S.C., Lu C.C., Shen Y.S., Yang Y.T., Wu S.R., Fang C.Y., Chow Y.H., Liao C.L., Chiang J.R., Liu C.C. Separation and purification of highly infectious enterovirus A71 particles using a strong anion-exchange column. J. Chromatogr. A. 2022;1680:463427. doi: 10.1016/j.chroma.2022.463427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chroma.2022.463427</ArticleId><ArticleId IdType="pubmed">36029731</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B., Forman M., Valsamakis A. Optimization and evaluation of a novel real-time RT-PCR test for detection of parechovirus in cerebrospinal fluid. J. Virol. Methods. 2019;272:113690. doi: 10.1016/j.jviromet.2019.113690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2019.113690</ArticleId><ArticleId IdType="pubmed">31283959</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>